1990
DOI: 10.1002/pros.2990170207
|View full text |Cite
|
Sign up to set email alerts
|

Primary yolk sac (endodermal sinus) tumor of the prostate: Case report and review of the literature

Abstract: A primary yolk sac (endodermal sinus) tumor of the prostate is described in a 40-year-old male. This is the second documented case of a yolk sac tumor occurring in the prostate gland. Treatment included surgical removal and subsequent combination chemotherapy. Four months following diagnosis, the patient died of complications. At autopsy, no residual tumor was detected. The role of combination chemotherapy as potentially curative therapy in the treatment of extragonadal yolk sac tumors is discussed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
12
0

Year Published

1992
1992
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 16 publications
0
12
0
Order By: Relevance
“…The first report of a positive response to cisplatinbased therapy was described in 1990 in a patient who received cisplatin, vinblastine, dactinomycin and bleomycin. Although the patient expired from postsurgical complications, autopsy revealed no evidence of tumor [3] . Two further cases demonstrated cisplatin-based therapy as successful [4,5] .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The first report of a positive response to cisplatinbased therapy was described in 1990 in a patient who received cisplatin, vinblastine, dactinomycin and bleomycin. Although the patient expired from postsurgical complications, autopsy revealed no evidence of tumor [3] . Two further cases demonstrated cisplatin-based therapy as successful [4,5] .…”
Section: Discussionmentioning
confidence: 99%
“…The patient relapsed 2 months following treatment and expired shortly thereafter. Another patient expired from relapse within 1 year of receiving two rounds of a cisplat- [2] 1988 CIS, BLEO yes died after 10 months Schriber [3] 1990 CIS, BLEO, VCR, DACT yes died after 4 months Tay [4] 1995 CIS, ETOP, BLEO* yes alive, free of disease Namiki [5] 1999 CIS, VLB, BLEO no alive, with disease Han [12] 2003 in, vinblastine and bleomycin, in addition to two rounds of adriablastin, etoposide, dactinomycin and methotrexate [2] . The first report of a positive response to cisplatinbased therapy was described in 1990 in a patient who received cisplatin, vinblastine, dactinomycin and bleomycin.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thirteen cases of extragonadal GCT of the prostate have been reported. The diagnosis of a primary GCT is made in the absence of concomitant GCT from usual sites of involvement (testis or mediastinum).The reported cases of prostatic GCT have occurred mostly in young adults with a mean age of 40.8 years (range 24–51 years); three patients had Klinefelter’s syndrome 211–223 . The clinical presentation includes haematuria, dysuria, obstructive symptoms, haemospermia, and pelvic pain.…”
Section: Germ Cell Tumour (Gct)mentioning
confidence: 99%
“…Additionally the possibility of a metastatic lesion from a testicular primary should be eliminated using the criteria of Abell et al As for treatment, it appears that patients who received preoperative combination chemotherapy 222,224,227 did better than patients who received their chemotherapy postoperatively. [219][220][221] This again emphasizes the importance of making the correct diagnosis on biopsy. The theories postulated for the origin of primary GCT of the prostate are similar to those put forward to explain the origin of extragonadal GCT in general.…”
mentioning
confidence: 91%